These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9930106)

  • 1. Cost of prostheses in patients with unilateral transtibial amputation for vascular disease. A population-based follow-up during 8 years of 112 patients.
    Hermodsson Y; Persson BM
    Acta Orthop Scand; 1998 Dec; 69(6):603-7. PubMed ID: 9930106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-efficacy issues in the treatment of peripheral vascular disease: primary amputation or revascularization for limb-threatening ischemia.
    Perler BA
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):111S-115S. PubMed ID: 8770853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of prosthetic costs and service between osseointegrated and conventional suspended transfemoral prostheses.
    Haggstrom EE; Hansson E; Hagberg K
    Prosthet Orthot Int; 2013 Apr; 37(2):152-60. PubMed ID: 22907950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with unilateral transfemoral amputation treated with a percutaneous osseointegrated prosthesis: a cost-effectiveness analysis.
    Hansson E; Hagberg K; Cawson M; Brodtkorb TH
    Bone Joint J; 2018 Apr; 100-B(4):527-534. PubMed ID: 29629586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and benefits of prosthetic vascular surgery.
    Callow AD; Mackey WC
    Int Surg; 1988; 73(4):237-40. PubMed ID: 3150842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-benefit analysis of saving the leg].
    Bruijnen H; Loeprecht H
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():617-9. PubMed ID: 2577606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome after trans-tibial amputation for vascular disease. A follow-up after eight years.
    Hermodsson Y; Ekdahl C; Persson BM
    Scand J Caring Sci; 1998; 12(2):73-80. PubMed ID: 9801627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modular socket system versus traditionally laminated socket: a cost analysis.
    Normann E; Olsson A; Brodtkorb TH
    Prosthet Orthot Int; 2011 Mar; 35(1):76-80. PubMed ID: 21515892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tibial angioplasty for limb salvage in high-risk patients and cost analysis.
    Werneck CC; Lindsay TF
    Ann Vasc Surg; 2009; 23(5):554-9. PubMed ID: 19632085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressure casting technique for transtibial prosthetic socket fit in developing countries.
    Lee PV; Lythgo N; Laing S; Lavranos J; Thanh NH
    J Rehabil Res Dev; 2014; 51(1):101-10. PubMed ID: 24805897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular reconstruction and/or amputation in severely handicapped patients].
    Schwilden ED
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():866-9. PubMed ID: 9102009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [When is there an indication for primary femoral amputation in patients with vascular disease?].
    Hepp W; Patschan R
    Zentralbl Chir; 1990; 115(14):865-71. PubMed ID: 2238962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2019; 19(7):1-126. PubMed ID: 31911825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic critical leg ischaemia--a cost benefit analysis.
    Luther M
    Ann Chir Gynaecol Suppl; 1997; 213():1-142. PubMed ID: 9373713
    [No Abstract]   [Full Text] [Related]  

  • 15. Sockets Manufactured by CAD/CAM Method Have Positive Effects on the Quality of Life of Patients With Transtibial Amputation.
    Karakoç M; Batmaz İ; Sariyildiz MA; Yazmalar L; Aydin A; Em S
    Am J Phys Med Rehabil; 2017 Aug; 96(8):578-581. PubMed ID: 28085736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic and economic impact of a modern amputation program.
    Malone JM; Moore WS; Goldstone J; Malone SJ
    Ann Surg; 1979 Jun; 189(6):798-802. PubMed ID: 453951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical leg ischaemia in New Zealand: economic cost of amputation versus intravenous iloprost.
    Scott HM; Scott WG
    Pharmacoeconomics; 1994 Aug; 6(2):149-54. PubMed ID: 10147440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of transgenicular amputation with dorsal skin-muscle flap-plasty in patients in the final stage of arterial occlusive disease].
    Kock HJ; Walz MK; Krause U; Klaes W; Eigler FW
    Chirurg; 1994 Nov; 65(11):1028-33. PubMed ID: 7821062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of treating advanced leg ischemia. Bypass graft vs primary amputation.
    Raviola CA; Nichter LS; Baker JD; Busuttil RW; Machleder HI; Moore WS
    Arch Surg; 1988 Apr; 123(4):495-6. PubMed ID: 3348741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment for chronic critical leg ischaemia: a 5 year follow-up of socioeconomic outcome.
    Luther M
    Eur J Vasc Endovasc Surg; 1997 May; 13(5):452-9. PubMed ID: 9166267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.